泰罗医疗公司以700万卢比收购了Vimta实验室在印度南部的诊断业务. Thyrocare acquires Vimta Labs' diagnostics business in Southern India for Rs 7 crore.

泰罗医疗技术有限公司以700万卢比收购Vimta实验室的诊断和病理服务业务, 扩大其在印度南部的业务, 服务更大客户群. Thyrocare Technologies Ltd acquires Vimta Labs' diagnostic and pathological services business for Rs 7 crore, expanding its presence in Southern India and servicing a larger customer base. 这笔交易旨在增加Thyrocare的市场份额,加强其在南印度的领导地位,并提供高质量,负担得起的诊断服务. The deal aims to increase Thyrocare's market share, strengthen its South India leadership position, and provide high-quality, affordable diagnostic services. 侧重于核心企业的Vimta实验室认为,撤资可提高业务效率。 Vimta Labs, focused on its core businesses, believes the divestment enhances operating efficiencies.